19 June 2013
Keywords: b-ms, approves, share, buy-back, rise, board, directors
Article | 07 May 1998
The board of directors at Bristol-Myers Squibb has approved a $2billion increase in the company's common stock buyback program, reports ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.